Healing characteristics of small-calibre vascular prostheses coated with plasmin-treated fibrin - An experimental study

Vasa - Journal of Vascular Diseases

Volumn 29, Issue 2, 2000, Pages 117-124

  Pfeiffer, Thomas ^a   Kever, M ^a   Grabitz, K ^a   Reiher, L ^a   Muller K M ^b   Hildebrand, A ^b   Sandmann, W ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Fibrin coated prostheses

Indexed keywords

FIBRIN; PLASMIN; POLYESTER;

ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PROSTHESIS; BYPASS SURGERY; CELL MIGRATION; CONTROLLED STUDY; DOG; GRAFT PATENCY; HEALING; MESENCHYME CELL; MICROSCOPY; NONHUMAN; VEIN GRAFT;

EID: 0034080077     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.29.2.117     Document Type: Article

References (80)

1. Abbas MA, Afshari NA, Stadius ML, Kernoff RS, Fischell TA. External beam irradiation inhibits neointimal hyperplasia following balloon angioplasty. Int J Cardiol 1994; 44: 191-202.
2. Amols HI, Reinstein LE, Weinberger J. Dosimetry of a radioactive coronary balloon dilatation catheter for treatment of neointimal hyperplasia. Med Phys 1996; 23: 1783-8.
3. Amols HI, Zaider M, Weinberger J, Ennis R, Schiff PB, Reinstein LE. Dosimetric considerations for catheter-based beta and gamma emitters in the therapy of neointimal hyperplasia in human coronary arteries. Int J Radiat Oncol Biol Phys 1996; 36: 913-21.
4. Ascer E, Veith F, Morin L, White-Flores SA, Scher LA, Samson RH, Weiser RK, Rivers S, Gupta SK. Quantitative assessment of outflow resistance in lower extremity arterial reconstructions. J Surg Res 1984; 37: 8-15.
5. Ascer E, Veith FJ, White-Flores SA, Morin L, Gupta SK, Lesser ML. Intraoperative outflow resistance as a predictor of late patency of femoropopliteal and infrapopliteal arterial bypasses. J Vasc Surg 1987; 5: 820-7.
6. Bauters C, Isner JM. The biology of restenosis. Prog Cardiovasc Dis 1997; 40: 107-16.
7. Brooks EE, Gray NS, Joly A, Kerwar SS, Lum R, Mackman RL, Norman TC, Rosete J, Rowe M, Schow SR, et al. CVT-313, a specific and potent inhibitor of CDK2 that prevents neointimal proliferation. J Biol Chem 1997; 272: 29207-11.
8. Buchwald AB, Hammerschmidt S, Stevens J, Goring J, Nebendahl K, Unterberg C. Inhibition of neointimal proliferation after coronary angioplasty by low-molecular-weight heparin (clivarine) and polyethyleneglycol-hirudin. J Cardiovasc Pharmacol 1996; 28: 481-7.
9. Burke SE, Lubbers NL, Gagne GD, Wessale JL, Dayton BD, Wegner CD, Opgenorth TJ. Selective antagonism of the ET(A) receptor reduces neointimal hyperplasia after balloon-induced vascular injury in pigs. J Cardiovasc Pharmacol 1997; 30: 33-41.
10. Calcagno D, Conte JV, Howell MH, Foegh ML. Peptide inhibition of neointimal hyperplasia in vein grafts. J Vasc Surg 1991; 13: 475-9.
11. Castronuovo JJ, Jr., Guss SB, Mysh D, Sawhney A, Wolff M, Gown AM. Cytokine therapy for arterial restenosis: inhibition of neointimal hyperplasia by gamma-interferon. Cardiovasc Surg 1995; 3: 463-8.
12. Chang MW, Barr E, Lu MM, Barton K, Leiden JM. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J Clin Invest 1995; 96: 2260-8.
13. Chen C, Lumsden AB, Ofenloch JC, Noe B, Campbell EJ, Stratford PW, Yianni YP, Taylor AS, Hanson SR. Phosphorylcholine coating of ePTFE grafts reduces neointimal hyperplasia in canine model. Ann Vasc Surg 1997; 11: 74-9.
14. Choi ET, Engel L, Callow AD, Sun S, Trachtenberg J, Santoro S, Ryan US. Inhibition of neointimal hyperplasia by blocking alpha V beta 3 integrin with a small peptide antagonist Gpen-GRGDSPCA. J Vasc Surg 1994; 19: 125-34.
15. Dasbach G, Voss B, Tiemann H, Müller K-M. Charakterisierung des zellulären Reaktionsmusters und der Bestandteile der Extrazellularmatrix nach Implantation von alloplastischenm Gefässersatz. Z Herz Thorax Gefächir 1990; 4: 21-4.
16. Donaldson MC, Mannick JA, Whiltemore AD. Femoral-distal bypass with in situ greater saphenous vein. Long term result us-ing the Mills valvulotome. Ann Surg 1991; 213: 457-65.
17. Ezaki Y, Takahasi M, Kobarai Y, Tukamoto A, Nagai H, Takano Y, Katakura T, Wakabayasi S. The animal study of new small caliber vascular graft (PF-V) in dogs. Jpn J Artif Organs 1994; 23: 763-9.
18. Ezaki Y, Takano Y, Nishihara K, Takahashi M, Katakura T. The effect of the high porous vascular graft coated with plasmin-treated fibrin on healing and patency. Jpn J Artif Organs 1992; 21: 268-74.
19. Geiger G, Hoevels J, Storz L, Bayer HP. Vascular grafts in below-knee femoro-popliteal bypass. A comparative study. J Cardiovasc Surg Torino. 1984; 25: 523-9.
20. Golino P, Ambrosio G, Ragni M, Cirillo P, Esposito N, Willerson JT, Rothlein R, Petrucci L, Condorelli M, Chiariello M, et al. Inhibition of leucocyte and platelet adhesion reduces neointimal hyperplasia after arterial injury. Thromb Haemost 1997; 77: 783-8.
21. Hamon M, Bauters C, McFadden EP, Wernert N, Lablanche JM, Dupuis B, Bertrand ME. Restenosis after coronary angioplasty. Eur Heart J 1995; 16 Suppl I: 33-48.
22. Hamon M, Lablanche JM, Bauters C, McFadden EP, Quandalle P, Bertrand ME. Effect of balloon inflation in angiographically normal coronary segments during coronary angioscopy: a quantitative angiographic study. Cathet Cardiovasc Diagn 1994; 31: 116-21.
23. Hehrlein C, Gollan C, Donges K, Metz J, Riessen R, Fehsenfeld P, von Hodenberg E, Kubler W. Low-dose radioactive endovascular stents prevent smooth muscle cell proliferation and neointimal hyperplasia in rabbits. Circulation 1995; 92: 1570-5.
24. Hiemer W, Uy J, Eberhard E, Gruss JD. Kniegelenküberschreitende Rekonstruktionen im Stadium II der arteriellen Verschlukrankheit. Vasomed 1995; 7: 19-22.
25. Hong MK, Kent KM, Mehran R, Mintz GS, Tio FO, Foegh M, Wong SC, Cathapermal SS, Leon MB. Continuous subcutaneous angiopeptin treatment significantly reduces neointimal hyperplasia in a porcine coronary in-stent restenosis model. Circulation 1997; 95: 449-54.
26. Hong MK, Kent KM, Tio FO, Foegh M, Kornowski R, Bramwell O, Cathapermal SS, Leon MB. Single-dose intramuscular administration of sustained-release Angiopeptin reduces neointimal hyperplasia in a porcine coronary in-stent restenosis model. Coron Artery Dis 1997; 8: 101-4.
27. Katsumura T, Nakajiama Y, Kubo Y, Sasujima T, Yasuda K, Ohuchi H, Shigematsu H, Iwai T, Ishimaru S, Ando M, et al. Multicenter clinical trial of a vascular prosthesis (TRE-651). Jpn J Vasc Surg 1998; 7: 605-13.
28. Kim YH, Chandran KB, Bower TJ, Corson JD. Flow dynamics across end-to-end vascular bypass graft anastomoses. Ann Biomed Eng 1993; 21: 311-20.
29. Kleinert LB, Hoying JB, Williams SK. The neointima formed in endothelial cell sodded ePTFE vascular grafts results from both cellular-hyperplasia and extracellular-hypertrophy. Cell Transplant 1996; 5: 475-82.
30. Kohler TR, Kirkman TR, Kraiss LW, Zierler BK, Clowes AW. Increased blood flow inhibits neointimal hyperplasia in endothelialized vascular grafts. Circ Res 1991; 69: 1557-65.
31. Kohler TR, Kirkman TR, Kraiss LW, Zierler BK, Clowes AW. Increased blood flow inhibits neointimal hyperplasia in endothelializedvascular grafts. Circ Res 1991; 69: 1557-65.
32. Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998; 31: 224-30.
33. Kraiss LW, Kirkman TR, Kohler TR, Zierler B, Clowes AW. Shear stress regulates smooth muscle proliferation and neointimal thickening in porous polytetrafluoroethylene grafts. Arterioscler Thromb 1991; 11: 1844-52.
34. Lafont A, Durand E, Rahal S, de Oliveira M, Guerin Y, Fernandez F, Desnos M, Guerot C. [Restenosis: physiopathology, treatments and prevention]. Ann Cardiol Angeiol Paris 1995; 44: 349-53.
35. Laird JR, Carter AJ, Kufs WM, Hoopes TG, Farb A, Nott SH, Fischell RE, Fischell DR. Virmani R, Fischell TA. Inhibition of neointimal proliferation with low-dose irradiation from a beta-particle-emitting stent. Circulation 1996; 93: 529-36.
36. Landzberg BR, Frishman WH, Lerrick K. Pathophysiology and pharmacological approaches for prevention of coronary artery restenosis following coronary artery balloon angioplasty and related procedures. Prog Cardiovasc Dis 1997; 39: 361-98.
37. Leclercq F, Grolleau R. (Mechanisms of restenosis after coronary angioplasty). Arch Mal Coeur Vaiss 1996; 89: 359-65.
38. Lumsden AB, Chen C, Coyle KA, Ofenloch JC, Wang JH, Yasuda HK, Hanson SR. Nonporous silicone polymer coating of expanded polytetrafluoroethylene grafts reduces graft neointimal hyperplasia in dog and baboon models. J Vasc Surg 1996; 24: 825-33.
39. Mann MJ, Dzau VJ. Genetic manipulation of vein grafts. Curr Opin Cardiol 1997; 12: 522-7.
40. Masashi I, Tadahiro S, Kazutomo G, Yuhichi I, Hiroki Y, Norifumi O. Experimental study of plasmin-treated fibrin impregnated vascular graft (PFIV) implanted in dog aorta. Jpn J Artif Organs 1995; 24: 120-4.
41. McCarty MF. Thalidomide may impede cell migration in primates by down-regulating integrin beta-chains: potential therapeutic utility in solid malignancies, proliferative retinopathy, inflammatory disorders, neointimal hyperplasia, and osteoporosis. Med Hypotheses 1997; 49: 123-31.
42. Mills NL, Everson CT. Vein graft failure. Curr Opin Cardiol 1995; 10: 562-8.
43. Morishita R, Gibbons GH, Ellison KE, Nakajima M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl Acad Sci 1993; 90: 8474-8.
44. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 1998; 97: 916-31.
45. Muller KM, Dasbach G. The pathology of vascular grafts. Curr Top Pathol 1994; 86: 273-306.
46. Nemecek GM, St. Denny IH, Van Valen RG, McCarthy LA, Handley DA, Stutz A. Terbinafine inhibits the mitogenic response to platelet-derived growth factor in vitro and neointimal proliferation in vivo. J Pharmacol Exp Ther 1989; 248: 1167-74.
47. Newman KD, Dunn PF, Owens JW, Schulick AH, Virmani R, Sukhova G, Libby P, Dichek DA. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest 1995; 96: 2955-65.
48. O'Brien JE, Jr., Shi Y, Fard A, Bauer T, Zalewski A, Mannion JD. Wound healing around and within saphenous vein bypass grafts. J Thorac Cardiovasc Surg 1997; 114: 38-45.
49. Park HY, Kang S. Kim GY, Jang Y, Kwon HM, Shim WH, Cho SY, Cho SH. Inhibition of neointimal proliferation of rat carotid artery by sulodexide. J Korean Med Sci 1997; 12: 210-4.
50. Pasic M, Muller Glauser W, Odermatt B, Lachat M, Seifert B, Turina M. Seeding with omental cells prevents late neointimal hyperplasia in small-diameter Dacron grafts. Circulation 1995; 92: 2605-16.
51. Pasic M, Muller Glauser W, Odermatt B, Lachat M, Seifert B, Turina M. Seeding with omental cells prevents late neointimal hyperplasia insmall-diameter Dacron grafts. Circulation 1995; 92: 2605-16.
52. Pastore CJ, Isner JM, Bacha PA, Kearney M, Pickering JG. Epidermal growth factor receptor-targeted cytotoxin inhibits neointimal hyperplasia in vivo. Results of local versus systemic administration. Circ Res 1995; 77: 519-29.
53. Peterkin GA, LaMorte WW, Menzoian JO. Runoff resistance and early graft failure in infrainguinal bypass surgery. Arch Surg 1988; 123: 1199-201.
54. Rogers C, Welt FG, Karnovsky MJ, Edelman ER. Monocyte recruitment and neointimal hyperplasia in rabbits. Coupled inhibitory effects of heparin. Arterioscler Thromb Vasc Biol 1996; 16: 1312-8.
55. Rosenthal D, Evans RD, McKinsey J, Seagraves MA, Lamis PA, Clare MD, Daniel WW. Prosthetic above-knee femoropopliteal bypass for intermittent claudication. J Cardiovasc Surg 1990; 31: 462-8.
56. Sandmann W, Kniemeyer HW, Jalschak R, Grabitz K. Operative Behandlung der peripheren arteriellen Verschluerkrankung bei Diabetes mellitus; in-situ-saphena-Bypass versus Umkehrbypassverfahren - eine retrospektive Studie. VASA 1990; 19: 47-53.
57. Sarac TP, Riggs PN, Williams JP, Feins RH, Baggs R, Rubin P, Green RM. The effects of low-dose radiation on neointimal hyperplasia. J Vasc Surg 1995; 22: 17-24.
58. Schwartz RS. The vessel wall reaction in restenosis. Semin Interv Cardiol 1997; 2: 83-8.
59. Schwartz RS, Chu A, Edwards WD, Srivatsa SS, Simari RD, Isner JM, Holmes DRJ. A proliferation analysis of arterial neointimal hyperplasia: lessons for antiproliferative restenosis therapies. Int J Cardiol 1996; 53: 71-80.
60. Schweiger H, Klein P, Lang W. Tibial bypass grafting for limb salvage with ringed polytetrafluoroethylene prostheses: results of primary and secondary procedures. J Vasc Surg 1993; 18: 867-74.
61. Shi Y, O'Brien JE, Jr., Mannion JD, Morrison RC, Chung W, Fard A, Zalewski A. Remodeling of autologous saphenous vein grafts. The role of perivascular myofibroblasts. Circulation 1997; 95: 2684-93.
62. Shimotakahara S, Mayberg MR. Gamma irradiation inhibits neointimal hyperplasia in rats after arterial injury. Stroke 1994; 25: 424-8.
63. Shinhara R. Antithrombogenicity and histocompatibility of plasmin-treated fibrin coating on small-caliber vascular prostheses. J Jap Coll Angiol 1993; 33: 1087-98.
64. Shinhara R, Fukuda Y, Kagawa N, Haruta N, Dohi K, Takano Y, Ezaki Y. Antitrombogenicity and healing characteristics of small-caliber prosthesis by plasmin-treated fibrin coating. Jpn J Vasc Surg 1993; 2: 1-7.
65. Shiroma H, Kusaba A. Ultrastructural features of progressive intimai hyperplasia at the distal end-to-side anastomosis of vein grafts. Cardiovasc Surg 1996; 4: 393-8.
66. Sottiurai VS, Yao JS, Flinn WR, Batson RC. Intimal hyperplasia and neointima: An ultrastructural analysis of thrombosed grafts in humans. Surgery 1983; 93: 809-17.
67. Suggs WD, Henriques HF, DePalma RG. Vein cuff interposition prevents juxta-anastomotic neointimal hyperplasia. Ann Surg 1988; 207: 717-23.
68. Tabuchi A. The long term study of healing process on internal surface of implanted small-caliber vascular prosthesis. J Jap Coll Angiol 1995; 35: 99-107.
69. Tabuchi A, Katsumura T, Fujiwara T, Murakami T, Inada H, Masaki H, Nagai R, Takano Y, Ezaki Y, Takahashi M. Long term study of the healing process on the internal surface of implanted small-caliber vascular prosteses, especially in the anastomotic region. Jpn J Vasc Surg 1995; 4: 359-66.
70. Taguchi J, Abe J, Ohno M, Schwartz SM, Kurokawa K. Topical application of ATI receptor antagonists prevents medial and neointimal proliferation after balloon injury. Blood Press Suppl 1994; 5: 38-42.
71. Takano Y, Ezaki Y, Sawamoto J. The small caliber prosthesis with healing characteristics. Jpn J Artif Organs 1991; 20: 580-5.
72. Tanigawa T, Ezaki Y, Kobarai Y, Tsukamoto Y, Hiraishi Y, Fujita K, Takano Y. A in vivo performances of plasmin treated fibrin impregnated vascular grafts. A comparative study with gelatin sealed dacron grafts in a dog model. Jpn J Artif Organs 1996; 25: 224-9.
73. Tomaru T, Yoshimura A, Inui K, Nakamura F, Omata M, Uchida Y. Local delivery of heparin inhibits neointimal hyperplasia in injured rabbit artery. Jpn Heart J 1995; 36: 657-68.
74. Tsukamoto A, Takano Y, Ezaki Y, Takahashi M, Kobarai Y, Studies on a fibrin matrix for small caliber vascular prosthesis. Jpn J Artif Organs 1995; 24: 924-30.
75. Varty K, Allen KE, Jones L, Sayers RD, Bell PR, London NJ. Influence of Losartan, an angiotensin receptor antagonist, on neointimal proliferation in cultured human saphenous vein. Br J Surg 1994; 81: 819-22.
76. Varty K, Porter K, Bell PR, London NJ. Vein morphology and bypass graft stenosis. Br J Surg 1996; 83: 1375-9.
77. Verin V, Popowski Y, Urban P, Belenger J, Redard M, Costa M, Widmer MC, Rouzaud M, Nouet P, Grob E, et al. Intra-arterial beta irradiation prevents neointimal hyperplasia in a hypercholesterolemic rabbit restenosis model. Circulation 1995; 92: 2284-90.
78. Villa AE, Guzman LA, Chen W, Golomb G, Levy RJ, Topol EJ. Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty. J Clin Invest 1994; 93: 1243-9.
79. Wilcox MG, Sawchuk AP. Neointimal hyperplasia following argon ion laser carotid endarterectomy: with and without endothelial cell seeding. Lasers Surg Med 1997; 20: 367-72.
80. Yonemitsu Y, Kaneda Y, Hata Y, Nakashima Y, Sueishi K. Wild-type p53 gene transfer: a novel therapeutic strategy for neointimal hyperplasia after arterial injury. Ann N Y Acad Sci 1997; 811: 395-400